Catalent, Inc. logo

Catalent, Inc.

NYSE:CTLT

Overview | Financials
Company Name Catalent, Inc.
Symbol CTLT
Currency USD
Price 60.32
Market Cap 10,945,908,480
Dividend Yield 0%
52-week-range 31.8 - 61.2
Industry Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Mr. Alessandro Maselli
Website https://www.catalent.com

An error occurred while fetching data.

About Catalent, Inc.

Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. It operates through four segments: Biologics, Softgel and Oral Technologies, Oral and Specialty Delivery, and Clinical Supply Services. The Softgel and Oral Technologies segment provides formulation, development,

Related Stocks

The Cooper Companies, Inc. logo

The Cooper Companies, Inc.

COO

110.53 USD

Quest Diagnostics Incorporated logo

Quest Diagnostics Incorporated

DGX

155.48 USD

Molina Healthcare, Inc. logo

Molina Healthcare, Inc.

MOH

355.15 USD

Waters Corporation logo

Waters Corporation

WAT

333.37 USD

Cardinal Health, Inc. logo

Cardinal Health, Inc.

CAH

111.41 USD

Bio-Rad Laboratories, Inc. logo

Bio-Rad Laboratories, Inc.

BIO-B

301 USD

Teleflex Incorporated logo

Teleflex Incorporated

TFX

241.53 USD

Financials

Numbers are in millions USD

Numbers are in millions USD